Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
Nature Medicine1996Vol. 2(7), pp. 811–814
Citations Over TimeTop 1% of 1996 papers
Turid Aas, Anne‐Lise Børresen, Stephanie Geisler, Birgitte Smith‐Sørensen, Hilde Johnsen, Jan Erik Varhaug, Lars A. Akslen, Per Eystein Lønning
Related Papers
- → Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model(2014)25 cited
- Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.(1994)
- Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.(1985)
- → [ID1 suppress the apoptosis of HCT116 cells induced by chemotherapeutic drugs and ultraviolet radiation].(2016)2 cited
- The killing effect of tumor necrosis factor related apoptosis-inducing ligand combined with chemotherapy drugs on glioblastoma cells(2011)